Keting Chu - Profile and Investment Details

Investor Profile

Keting Chu is a Venture Capital based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences, Baixing Pingan Yaofang, ABclonal, Ansun BioPharma, Sciwind Biosciences, HiFiBiO, Nucleix, Laviana Pharma, Edge Medical Robotics, Cleveland Diagnostics, Zhenge Biotech, Just Medical, CANbridge Pharmaceuticals, Burning Rock Biotech, WinnTi Medical. Over time, Keting Chu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Keting Chu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Medical Testing, Life Science, Information Technology (IT), Medical Device, Manufacturing, Biotechnology, Genomics, Health Diagnostics, Personal Health, Pharmaceuticals, Biometrics, Biopharma may find it worthwhile to explore potential connections with Keting Chu, as their portfolio suggests a familiarity and interest in this area.

Understanding Keting Chu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.